{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:56:31Z","timestamp":1791669391887,"version":"4.3.4"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01824-w","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:24:50Z","timestamp":1774081490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The metabolic roots of memory loss: interlinking the Diabetes-Alzheimer\u2019s hypothesis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-8851","authenticated-orcid":false,"given":"Tanya","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-0797","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Randhir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"7","key":"1824_CR1","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.4239\/wjd.v15.i7.1430","volume":"15","author":"MMI Abdalla","year":"2024","unstructured":"Abdalla MMI (2024) Insulin resistance as the molecular link between diabetes and Alzheimer\u2019s disease. World J Diabetes 15(7):1430\u20131447. https:\/\/doi.org\/10.4239\/wjd.v15.i7.1430","journal-title":"World J Diabetes"},{"key":"1824_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021122","author":"A Abdyeva","year":"2024","unstructured":"Abdyeva A, Kurtova E, Savinkova I, Galkov M, Gorbacheva L (2024) Long-term exposure of cultured astrocytes to high glucose impact on their LPS-induced activation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25021122","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1824_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.4103\/1673-5374.386406","volume":"19","author":"M Abyadeh","year":"2024","unstructured":"Abyadeh M, Gupta V, Paulo JA, Mahmoudabad AG, Shadfar S, Mirshahvaladi S, Gupta V, Nguyen CTO, Finkelstein DI, You Y, Haynes PA, Salekdeh GH, Graham SL, Mirzaei M (2024) Amyloid-beta and tau protein beyond Alzheimer\u2019s disease. Neural Regen Res 19(6):1262\u20131276. https:\/\/doi.org\/10.4103\/1673-5374.386406","journal-title":"Neural Regen Res"},{"key":"1824_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f4d7f8","author":"S Ahtiluoto","year":"2010","unstructured":"Ahtiluoto S, Polvikoski T, Peltonen M (2010) Diabetes, Alzheimer disease, and vascular dementia. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f4d7f8","journal-title":"Neurology"},{"issue":"13","key":"1824_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu16132156","volume":"16","author":"O Albitar","year":"2024","unstructured":"Albitar O, D\u2019Souza CM, Adeghate EA (2024) Effects of lipoproteins on metabolic health. Nutrients 16(13):1\u201315. https:\/\/doi.org\/10.3390\/nu16132156","journal-title":"Nutrients"},{"key":"1824_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137182","author":"S Alfei","year":"2024","unstructured":"Alfei S, Schito GC, Schito AM, Zuccari G (2024) Reactive oxygen species (ROS)-mediated antibacterial oxidative therapies: available methods to generate ROS and a novel option proposal. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137182","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1824_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-023-01082-1","volume":"15","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Saad HM, Batiha GES (2023) The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer\u2019s diseases. Diabetol Metab Syndr 15(1):1\u201316. https:\/\/doi.org\/10.1186\/s13098-023-01082-1","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1824_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-023-00966-z","volume":"13","author":"A Arjunan","year":"2023","unstructured":"Arjunan A, Sah DK, Woo M, Song J (2023) Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell Biosci 13(1):1\u201318. https:\/\/doi.org\/10.1186\/s13578-023-00966-z","journal-title":"Cell Biosci"},{"issue":"3","key":"1824_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185.Brain","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-rambach SL, Koenig AM, Stoeckel LE, Holtzman DM, Nathan DM, Street H (2018) HHS Public Access 14(3):168\u2013181. https:\/\/doi.org\/10.1038\/nrneurol.2017.185.Brain","journal-title":"HHS Public Access"},{"key":"1824_CR10","doi-asserted-by":"publisher","unstructured":"Avitan I, Halperin Y, Saha T, Bloch N, Atrahimovich D, Polis B, Samson AO, Braitbard O (2021) Towards a Consensus on Alzheimer\u2019s Disease Comorbidity? J Clin Med 10(19):4360. https:\/\/doi.org\/10.3390\/jcm10194360","DOI":"10.3390\/jcm10194360"},{"issue":"4","key":"1824_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11095-022-03237-7","volume":"39","author":"MS Azam","year":"2022","unstructured":"Azam MS, Wahiduzzaman M, Reyad-ul-Ferdous M, Islam MN, Roy M (2022) Inhibition of insulin degrading enzyme to control diabetes mellitus and its applications on some other chronic disease: a critical review. Pharm Res 39(4):611\u2013629. https:\/\/doi.org\/10.1007\/s11095-022-03237-7","journal-title":"Pharm Res"},{"issue":"1","key":"1824_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain 17(1):1\u201324. https:\/\/doi.org\/10.1186\/s13041-024-01118-1","journal-title":"Mol Brain"},{"issue":"1","key":"1824_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA (2012) Pharmacology & therapeutics insulin in the brain\u202f: there and back again. Pharmacol Ther 136(1):82\u201393. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.006","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1824_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, Pappolla MA, Sambamurti K, Alzheimer C, Author R (2015) Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer\u2019s Disease HHS Public Access Author manuscript. Curr Alzheimer Res 12(1):32\u201346","journal-title":"Curr Alzheimer Res"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2021.09.006","volume":"176","author":"E Barone","year":"2021","unstructured":"Barone E, Di Domenico F, Perluigi M, Butterfield DA (2021) The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease. Free Radic Biol Med 176:16\u201333. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.09.006","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1824_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","volume":"245","author":"AF Batista","year":"2018","unstructured":"Batista AF, Forny-Germano L, Clarke JR, Lyra e Silva NM, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF, Marques SA, Martinez AMB, Gralle M, Holscher C, Klein WL, Houzel JC, Ferreira ST, Munoz DP, De Felice FG (2018) The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease. J Pathol 245(1):85\u2013100. https:\/\/doi.org\/10.1002\/path.5056","journal-title":"J Pathol"},{"key":"1824_CR17","doi-asserted-by":"publisher","unstructured":"Beard E, Lengacher S, Dias S, Magistretti PJ, Finsterwald C (2022) Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives. Front Physiol 12(January). https:\/\/doi.org\/10.3389\/fphys.2021.825816","DOI":"10.3389\/fphys.2021.825816"},{"issue":"1","key":"1824_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar K, Konerth M, Kokiko-cochran ON, Cardona A, Ransohoff RM, Lamb BT (2010) Article regulation of tau pathology by the microglial fractalkine receptor. Neuron 68(1):19\u201331. https:\/\/doi.org\/10.1016\/j.neuron.2010.08.023","journal-title":"Neuron"},{"issue":"10","key":"1824_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1824_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated A\u03b2 oligomers. J Clin Invest 122(4):1339\u20131353. https:\/\/doi.org\/10.1172\/JCI57256","journal-title":"J Clin Invest"},{"issue":"43","key":"1824_CR21","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1523\/JNEUROSCI.0730-19.2019","volume":"39","author":"JA Bonds","year":"2019","unstructured":"Bonds JA, Shetti A, Bheri A, Chen Z, Disouky A, Tai L, Mao M, Head BP, Bonini MG, Haus JM, Minshal RD, Lazarov O (2019) Depletion of caveolin-1 in type 2 diabetes model induces alzheimer\u2019s disease pathology precursors. J Neurosci 39(43):8576\u20138583. https:\/\/doi.org\/10.1523\/JNEUROSCI.0730-19.2019","journal-title":"J Neurosci"},{"issue":"SUPPL","key":"1824_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2004.04.032","volume":"337","author":"J Boonstra","year":"2004","unstructured":"Boonstra J, Post JA (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337(SUPPL):1\u201313. https:\/\/doi.org\/10.1016\/j.gene.2004.04.032","journal-title":"Gene"},{"issue":"1","key":"1824_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2023.119575","volume":"1871","author":"A Borek-Dorosz","year":"2024","unstructured":"Borek-Dorosz A, Pieczara A, Orleanska J, Brzozowski K, Tipping W, Graham D, Bik E, Kubrak A, Baranska M, Majzner K (2024) Raman microscopy reveals how cell inflammation activates glucose and lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871(1):119575. https:\/\/doi.org\/10.1016\/j.bbamcr.2023.119575","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1824_CR24","doi-asserted-by":"publisher","unstructured":"Botella Lucena P, Heneka MT (2024) Inflammatory aspects of Alzheimer\u2019s disease. Acta Neuropathol 148(1). https:\/\/doi.org\/10.1007\/s00401-024-02790-2","DOI":"10.1007\/s00401-024-02790-2"},{"issue":"October","key":"1824_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2021.730829","volume":"12","author":"JC Bozelli","year":"2021","unstructured":"Bozelli JC, Azher S, Epand RM (2021) Plasmalogens and chronic inflammatory diseases. Front Physiol 12(October):1\u201319. https:\/\/doi.org\/10.3389\/fphys.2021.730829","journal-title":"Front Physiol"},{"key":"1824_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/S0003598X00113821","author":"D Brothwell","year":"2005","unstructured":"Brothwell D (2005) Diseases. Antiquity. https:\/\/doi.org\/10.1017\/S0003598X00113821","journal-title":"Antiquity"},{"issue":"4","key":"1824_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11011-014-9631-3","volume":"30","author":"Z Cai","year":"2015","unstructured":"Cai Z, Xiao M, Chang L, Yan LJ (2015) Role of insulin resistance in Alzheimer\u2019s disease. Metab Brain Dis 30(4):839\u2013851. https:\/\/doi.org\/10.1007\/s11011-014-9631-3","journal-title":"Metab Brain Dis"},{"key":"1824_CR28","doi-asserted-by":"publisher","unstructured":"Campbell JM, Stephenson MD, Courten B, De, Chapman I, Bellman SM, Aromataris E (2018) Un co rre cte d Au tho r P roo f Metformin Use Associated with Reduced cte d Au tho r P roo f Un. https:\/\/doi.org\/10.3233\/JAD-180263","DOI":"10.3233\/JAD-180263"},{"key":"1824_CR29","doi-asserted-by":"crossref","unstructured":"Cerasuolo M, Auriemma MC, Meo I, Di, Lenti C, Papa M, Paolisso G, Rizzo MR (2025) Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer \u2019 s Disease and A \u03b2 Plaque Management. 1\u201318","DOI":"10.3390\/ijms26146693"},{"issue":"3","key":"1824_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pathophys.2006.05.004","volume":"13","author":"V Chauhan","year":"2006","unstructured":"Chauhan V, Chauhan A (2006) Oxidative stress in Alzheimer\u2019s disease. Pathophysiology 13(3):195\u2013208. https:\/\/doi.org\/10.1016\/j.pathophys.2006.05.004","journal-title":"Pathophysiology"},{"key":"1824_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4111","author":"A Chauhan","year":"2024","unstructured":"Chauhan A, Dubey S, Jain S (2024) Association between type 2 diabetes mellitus and Alzheimer\u2019s disease: common molecular mechanism and therapeutic targets. Cell Biochem Funct. https:\/\/doi.org\/10.1002\/cbf.4111","journal-title":"Cell Biochem Funct"},{"key":"1824_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.05.016","author":"H Chen","year":"2017","unstructured":"Chen H, Chan DC (2017) Review mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2017.05.016","journal-title":"Cell Metab"},{"issue":"August","key":"1824_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103321","volume":"76","author":"C Chen","year":"2024","unstructured":"Chen C, Wang J, Zhang S, Zhu X, Hu J, Liu C, Liu L (2024) Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis. Redox Biol 76(August):103321. https:\/\/doi.org\/10.1016\/j.redox.2024.103321","journal-title":"Redox Biol"},{"issue":"1","key":"1824_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12655","volume":"29","author":"Y Chornenkyy","year":"2019","unstructured":"Chornenkyy Y, Wang WX, Wei A, Nelson PT (2019) Alzheimer\u2019s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline. Brain Pathol 29(1):3\u201317. https:\/\/doi.org\/10.1111\/bpa.12655","journal-title":"Brain Pathol"},{"issue":"3","key":"1824_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159x11311030006","volume":"11","author":"MB Colovic","year":"2013","unstructured":"Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11(3):315\u2013335. https:\/\/doi.org\/10.2174\/1570159x11311030006","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1824_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.50.1.164","volume":"50","author":"S Craft","year":"1998","unstructured":"Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50(1):164\u2013168. https:\/\/doi.org\/10.1212\/WNL.50.1.164","journal-title":"Neurology"},{"key":"1824_CR37","doi-asserted-by":"publisher","unstructured":"Craft S, Cholerton B, Baker LD (2012) Insulin and Alzheimer \u2019 s Disease: Untangling rre cte d Un Au tho r P roo f roo f Un co rre cte d Au tho r P. https:\/\/doi.org\/10.3233\/JAD-2012-129042","DOI":"10.3233\/JAD-2012-129042"},{"key":"1824_CR38","doi-asserted-by":"publisher","unstructured":"Craft S, Raman R, Chow TW, Rafii MS, Sun C, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS (2020) Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia A Randomized Clinical Trial. 27157. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1840","DOI":"10.1001\/jamaneurol.2020.1840"},{"key":"1824_CR39","unstructured":"Creegan R (2014) Identification of plasma lipid biomarkers in Alzheimer\u2019s disease. http:\/\/ro.ecu.edu.au\/theses\/1340\/"},{"key":"1824_CR40","doi-asserted-by":"publisher","unstructured":"Cummings JL, Zhou Y, Lee G, Zhong K, Fonseca J, Leisgang-osse AM, Cheng F (2025) Alzheimer \u2019 s disease drug development pipeline: 2025. March, 1\u201310. https:\/\/doi.org\/10.1002\/trc2.70098","DOI":"10.1002\/trc2.70098"},{"key":"1824_CR41","doi-asserted-by":"publisher","unstructured":"Curieses Andr\u00e9s CM, de la P\u00e9rez JM, Andr\u00e9s Juan C, Plou FJ, P\u00e9rez-Lebe\u00f1a E (2023) From reactive species to disease development: Effect of oxidants and antioxidants on the cellular biomarkers. J Biochem Mol Toxicol 37(11). https:\/\/doi.org\/10.1002\/jbt.23455","DOI":"10.1002\/jbt.23455"},{"issue":"3","key":"1824_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.exger.2009.12.004","volume":"45","author":"M D\u2019Amico","year":"2010","unstructured":"D\u2019Amico M, Di Filippo C, Marfella R, Abbatecola AM, Ferraraccio F, Rossi F, Paolisso G (2010) Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer\u2019s prone mice. Exp Gerontol 45(3):202\u2013207. https:\/\/doi.org\/10.1016\/j.exger.2009.12.004","journal-title":"Exp Gerontol"},{"key":"1824_CR43","doi-asserted-by":"publisher","DOI":"10.1515\/ohe-2023-0025","author":"MA Dar","year":"2024","unstructured":"Dar MA, Qadrie Z, Maqbool M, Ara I, Qadir A (2024) Metabolic mysteries of the mind: investigating type 3 diabetes. Open Health. https:\/\/doi.org\/10.1515\/ohe-2023-0025","journal-title":"Open Health"},{"key":"1824_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1225578","author":"AJPO De Almeida","year":"2022","unstructured":"De Almeida AJPO, De Oliveira JCPL, Da Silva Pontes LV, De Souza J\u00fanior JF, Gon\u00e7alves TAF, Dantas SH, De Almeida Feitosa MS, Silva AO, De Medeiros IA (2022) ROS: basic concepts, sources, cellular signaling, and its implications in aging pathways. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/1225578","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1824_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4239\/wjd.v14.i2.76","volume":"14","author":"B la De Cruz Concepci\u00f3n","year":"2023","unstructured":"la De Cruz Concepci\u00f3n B, Cortez YAF, Bonilla MIB, Bello JMM, Rojo ME (2023) Insulin: a connection between pancreatic \u03b2 cells and the hypothalamus. World J Diabetes 14(2):76\u201391. https:\/\/doi.org\/10.4239\/wjd.v14.i2.76","journal-title":"World J Diabetes"},{"issue":"4","key":"1824_CR46","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SM De La Monte","year":"2014","unstructured":"De La Monte SM, Tong M (2014) Brain metabolic dysfunction at the core of Alzheimer\u2019s disease. Biochem Pharmacol 88(4):548\u201359. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.012","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1824_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1567205013666160930110551","volume":"14","author":"B Decourt","year":"2016","unstructured":"Decourt B, Lahiri DK, Sabbagh MN (2016) Targeting tumor necrosis factor alpha for Alzheimer\u2019s disease. Curr Alzheimer Res 14(4):412\u2013425. https:\/\/doi.org\/10.2174\/1567205013666160930110551","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"1824_CR48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53(7):1270\u20131287. https:\/\/doi.org\/10.1007\/s00125-010-1684-1","journal-title":"Diabetologia"},{"key":"1824_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0333-5","author":"MA Deture","year":"2019","unstructured":"Deture MA, Dickson DW, BioMed Central Ltd (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"P1","key":"1824_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","volume":"193","author":"S Dewanjee","year":"2022","unstructured":"Dewanjee S, Chakraborty P, Bhattacharya H, Chacko L, Singh B, Chaudhary A, Javvaji K, Pradhan SR, Vallamkondu J, Dey A, Kalra RS, Jha NK, Jha SK, Reddy PH, Kandimalla R (2022) Altered glucose metabolism in Alzheimer\u2019s disease: role of mitochondrial dysfunction and oxidative stress. Free Radic Biol Med 193(P1):134\u2013157. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.09.032","journal-title":"Free Radic Biol Med"},{"issue":"May","key":"1824_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105061","volume":"145","author":"F Dorninger","year":"2020","unstructured":"Dorninger F, Forss-Petter S, Wimmer I, Berger J (2020) Plasmalogens, platelet-activating factor and beyond \u2013 ether lipids in signaling and neurodegeneration. Neurobiol Dis 145(May):105061. https:\/\/doi.org\/10.1016\/j.nbd.2020.105061","journal-title":"Neurobiol Dis"},{"issue":"1663","key":"1824_CR52","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1098\/rspb.2008.1791","volume":"276","author":"DK Dowling","year":"2009","unstructured":"Dowling DK, Simmons LW (2009) Reactive oxygen species as universal constraints in life-history evolution. Proc R Soc Lond B Biol Sci 276(1663):1737\u20131745. https:\/\/doi.org\/10.1098\/rspb.2008.1791","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"FEB","key":"1824_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2014.00022","volume":"8","author":"NB El Khoury","year":"2014","unstructured":"El Khoury NB, Gratuze M, Papon MA, Bretteville A, Planel E (2014) Insulin dysfunction and tau pathology. Front Cell Neurosci 8(FEB):1\u201318. https:\/\/doi.org\/10.3389\/fncel.2014.00022","journal-title":"Front Cell Neurosci"},{"key":"1824_CR54","doi-asserted-by":"publisher","unstructured":"Emrani S, Arain HA, Demarshall C, Nuriel T (2020) APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer\u2019s disease: a systematic review. Alzheimers Res Ther 12(1):141 . https:\/\/doi.org\/10.1186\/s13195-020-00712-4","DOI":"10.1186\/s13195-020-00712-4"},{"issue":"9","key":"1824_CR55","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1007\/s12035-018-0868-4","volume":"55","author":"M Ettcheto","year":"2018","unstructured":"Ettcheto M, S\u00e1nchez-L\u00f3pez E, G\u00f3mez-M\u00ednguez Y, Cabrera H, Busquets O, Beas-Zarate C, Garc\u00eda ML, Carro E, Casadesus G, Auladell C, V\u00e1zquez Carrera M, Folch J, Camins A (2018) Peripheral and central effects of memantine in a mixed preclinical mice model of obesity and familial Alzheimer\u2019s disease. Mol Neurobiol 55(9):7327\u20137339. https:\/\/doi.org\/10.1007\/s12035-018-0868-4","journal-title":"Mol Neurobiol"},{"key":"1824_CR56","doi-asserted-by":"publisher","unstructured":"Fang F, Lue L, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, Chen JX, Yan SS (2010) RAGE-dependent signaling in microglia contributes to neuroinflammation, A \u2424 accumulation, and impaired learning \/ memory in a mouse model of Alzheimer \u2019 s disease. 1043\u20131055. https:\/\/doi.org\/10.1096\/fj.09-139634","DOI":"10.1096\/fj.09-139634"},{"key":"1824_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101208","author":"H Fanlo-Ucar","year":"2024","unstructured":"Fanlo-Ucar H, Pic\u00f3n-Pag\u00e8s P, Herrera-Fern\u00e1ndez V, ILL-Raga G, Mu\u00f1oz FJ (2024) The dual role of amyloid beta-peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer\u2019s disease etiopathology. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13101208","journal-title":"Antioxidants"},{"issue":"1","key":"1824_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12698","volume":"9","author":"MT Fatima","year":"2023","unstructured":"Fatima MT, Bhat AA, Nisar S, Fakhro KA, Al-Shabeeb Akil AS (2023) The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: an assessment of the benefit profile. Heliyon 9(1):e12698. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12698","journal-title":"Heliyon"},{"key":"1824_CR59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2018.10.012","volume":"144","author":"V Fawzy Fahim","year":"2019","unstructured":"Fawzy Fahim V, Wadie W, Shafik AN, Ishak Attallah M (2019) Role of simvastatin and insulin in memory protection in a rat model of diabetes mellitus and dementia. Brain Res Bull 144:21\u201327. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.10.012","journal-title":"Brain Res Bull"},{"key":"1824_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07839.x","author":"L Fr\u00f6lich","year":"1999","unstructured":"Fr\u00f6lich L, Blum-degen D, Riederer P, Hoyer S (1999) A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer \u2019 s disease. Ann N Y Acad Sci. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb07839.x","journal-title":"Ann N Y Acad Sci"},{"key":"1824_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2018.11.008","volume":"75","author":"S Gabbouj","year":"2019","unstructured":"Gabbouj S, Natunen T, Koivisto H, Jokivarsi K, Takalo M, Marttinen M, Wittrahm R, Kemppainen S, Naderi R, Posado-Fern\u00e1ndez A, Ryh\u00e4nen S, M\u00e4kinen P, Paldanius KMA, Doria G, Poutiainen P, Flores O, Haapasalo A, Tanila H, Hiltunen M (2019a) Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP\/PS1 Alzheimer model mice. Neurobiol Aging 75:98\u2013108. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.11.008","journal-title":"Neurobiol Aging"},{"issue":"JUN","key":"1824_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00629","volume":"13","author":"S Gabbouj","year":"2019","unstructured":"Gabbouj S, Ryh\u00e4nen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S, Martiskaine H, Tanila H, Haapasalo A, Hiltunen M, Natunen T (2019) Altered insulin signaling in Alzheimer\u2019s disease brain-special emphasis on pi3k-akt pathway. Front Neurosci 13(JUN):1\u20138. https:\/\/doi.org\/10.3389\/fnins.2019.00629","journal-title":"Front Neurosci"},{"key":"1824_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060943","author":"G Galizzi","year":"2022","unstructured":"Galizzi G, Di Carlo M (2022) Insulin and its key role for mitochondrial function\/dysfunction and quality control: a shared link between dysmetabolism and neurodegeneration. Biology. https:\/\/doi.org\/10.3390\/biology11060943","journal-title":"Biology"},{"issue":"3","key":"1824_CR64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/bpa.12116","volume":"24","author":"C Gao","year":"2014","unstructured":"Gao C, Liu Y, Jiang Y, Ding J, Li L (2014) Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3\u03b2 pathway in streptozotocin-induced alzheimer rat model. Brain Pathol 24(3):261\u2013269. https:\/\/doi.org\/10.1111\/bpa.12116","journal-title":"Brain Pathol"},{"key":"1824_CR65","doi-asserted-by":"publisher","unstructured":"Gejl M, Gjedde A, Egefjord L, M\u00f8ller A, Hansen SB, Vang K, Rodell A, Br\u00e6ndgaard H, Gottrup H, Schacht A, M\u00f8ller N, Brock B, Rungby J (2016) In Alzheimer \u2019 s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism : Randomized, Clinical Trial. 8(May), 1\u201310. https:\/\/doi.org\/10.3389\/fnagi.2016.00108","DOI":"10.3389\/fnagi.2016.00108"},{"key":"1824_CR66","doi-asserted-by":"publisher","unstructured":"Gon\u00e7alves PB, Sodero ACR, Cordeiro Y (2024) Natural products targeting amyloid-\u03b2 oligomer neurotoxicity in Alzheimer\u2019s disease. Eur J Med Chem 276(June). https:\/\/doi.org\/10.1016\/j.ejmech.2024.116684","DOI":"10.1016\/j.ejmech.2024.116684"},{"issue":"1","key":"1824_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-022-00996-8","volume":"14","author":"A Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez A, Calf\u00edo C, Churruca M, Maccioni RB (2022) Glucose metabolism and AD: evidence for a potential diabetes type 3. Alzheimers Res Ther 14(1):1\u201311. https:\/\/doi.org\/10.1186\/s13195-022-00996-8","journal-title":"Alzheimers Res Ther"},{"key":"1824_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccb.2023.100190","volume":"6","author":"PB Gorelick","year":"2024","unstructured":"Gorelick PB, Sorond FA (2024) What is brain health? Cerebral Circulation - Cognition and Behavior 6:100190. https:\/\/doi.org\/10.1016\/j.cccb.2023.100190","journal-title":"Cerebral Circulation - Cognition and Behavior"},{"issue":"4","key":"1824_CR69","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-2009-0976","volume":"16","author":"I Granic","year":"2009","unstructured":"Granic I, Dolga AM, Nijholt IM, Van Dijk G, Eisel ULM (2009) Inflammation and NF-\u03baB in Alzheimer\u2019s disease and diabetes. J Alzheimers Dis 16(4):809\u2013821. https:\/\/doi.org\/10.3233\/JAD-2009-0976","journal-title":"J Alzheimers Dis"},{"issue":"21","key":"1824_CR70","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/j.issn.1673-5374.2013.21.009","volume":"8","author":"CY Guo","year":"2013","unstructured":"Guo CY, Sun L, Chen XP, Zhang DS (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003\u20132014. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"issue":"3","key":"1824_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells11030559","volume":"11","author":"M Gupte","year":"2022","unstructured":"Gupte M, Tousif S, Lemon JJ, Cora AT, Umbarkar P, Lal H (2022) Isoform-specific role of GSK-3 in high fat diet induced obesity and glucose intolerance. Cells 11(3):1\u201312. https:\/\/doi.org\/10.3390\/cells11030559","journal-title":"Cells"},{"key":"1824_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116158","volume":"171","author":"Y Hai","year":"2024","unstructured":"Hai Y, Ren K, Zhang Y, Yang L, Cao H, Yuan X, Su L, Li H, Feng X, Liu D (2024) HIF-1\u03b1 serves as a co-linker between AD and T2DM. Biomed Pharmacother 171:116158. https:\/\/doi.org\/10.1016\/j.biopha.2024.116158","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1824_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s001250051596","volume":"44","author":"E Hajduch","year":"2001","unstructured":"Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS, Downes CP, Hundal HS (2001) Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44(2):173\u2013183. https:\/\/doi.org\/10.1007\/s001250051596","journal-title":"Diabetologia"},{"issue":"2","key":"1824_CR74","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.dsx.2019.01.040","volume":"13","author":"M Halim","year":"2019","unstructured":"Halim M, Halim A (2019) The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metabolic Syndrome: Clin Res Reviews 13(2):1165\u20131172. https:\/\/doi.org\/10.1016\/j.dsx.2019.01.040","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"key":"1824_CR75","doi-asserted-by":"publisher","unstructured":"Hampe CS, Mitoma H, Manto M (2018) GABA and Glutamate: Their Transmitter Role in the CNS and Pancreatic Islets. GABA And Glutamate - New Developments In Neurotransmission Research. https:\/\/doi.org\/10.5772\/intechopen.70958","DOI":"10.5772\/intechopen.70958"},{"issue":"10","key":"1824_CR76","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1824_CR77","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2337\/db08-1228","volume":"58","author":"JM Haus","year":"2009","unstructured":"Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, Kirwan JP (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58(2):337\u2013343. https:\/\/doi.org\/10.2337\/db08-1228","journal-title":"Diabetes"},{"key":"1824_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Kummer MP (2015) Neuroinfl ammation in Alzheimer \u2019 s disease. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"April","key":"1824_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105766","volume":"170","author":"RE Henn","year":"2022","unstructured":"Henn RE, Noureldein MH, Elzinga SE, Kim B, Savelieff MG, Feldman EL (2022) Glial-neuron crosstalk in health and disease: a focus on metabolism, obesity, and cognitive impairment. Neurobiol Dis 170(April):105766. https:\/\/doi.org\/10.1016\/j.nbd.2022.105766","journal-title":"Neurobiol Dis"},{"key":"1824_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030312","author":"Y Hong","year":"2024","unstructured":"Hong Y, Boiti A, Vallone D, Foulkes NS (2024) Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13030312","journal-title":"Antioxidants"},{"issue":"5","key":"1824_CR81","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41574-020-0329-9.Insulin","volume":"16","author":"BD Hopkins","year":"2021","unstructured":"Hopkins BD, Goncalves MD, Cantley LC, Sciences G, Medicine WC, Medicine WC (2021) HHS Public Access 16(5):276\u2013283. https:\/\/doi.org\/10.1038\/s41574-020-0329-9.Insulin","journal-title":"HHS Public Access"},{"issue":"12","key":"1824_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0083508","volume":"8","author":"MS Hossain","year":"2013","unstructured":"Hossain MS, Ifuku M, Take S, Kawamura J, Miake K, Katafuchi T (2013) Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling. PLoS One 8(12):1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0083508","journal-title":"PLoS One"},{"issue":"3","key":"1824_CR83","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10528-021-10154-8","volume":"60","author":"C Huang","year":"2022","unstructured":"Huang C, Luo J, Wen X, Li K (2022) Linking diabetes mellitus with Alzheimer\u2019s disease: bioinformatics analysis for the potential pathways and characteristic genes. Biochem Genet 60(3):1049\u20131075. https:\/\/doi.org\/10.1007\/s10528-021-10154-8","journal-title":"Biochem Genet"},{"key":"1824_CR84","doi-asserted-by":"publisher","unstructured":"Inoue K, Tsutsui H, Akatsu H, Hashizume Y, Matsukawa N, Yamamoto T (2013) Metabolic profiling of Alzheimer\u2019s disease brains. 1\u20139. https:\/\/doi.org\/10.1038\/srep02364","DOI":"10.1038\/srep02364"},{"key":"1824_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1769-z","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-saecker A, Schwartz S, Albasset S, Mcmanus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Heneka MT (2019) NLRP3 inflammasome activation drives tau pathology. March. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"March"},{"issue":"4","key":"1824_CR86","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Budd S, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Luis J, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Silverberg N (2018) NIA-AA research framework: toward a biological definition of Alzheimer \u2019 s disease. Alzheimers Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"issue":"June","key":"1824_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155640","volume":"146","author":"PRE Jarvis","year":"2023","unstructured":"Jarvis PRE, Cardin JL, Nisevich-Bede PM, McCarter JP (2023) Continuous glucose monitoring in a healthy population: understanding the post-prandial glycemic response in individuals without diabetes mellitus. Metabolism 146(June):155640. https:\/\/doi.org\/10.1016\/j.metabol.2023.155640","journal-title":"Metabolism"},{"key":"1824_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s44187-024-00186-5","author":"J Jayaprakash","year":"2024","unstructured":"Jayaprakash J, Nath LR, Siddabasave SG, Gowda D, Hui SP (2024) Analysis and functions of bioactive lipids in food. Discover Food. https:\/\/doi.org\/10.1007\/s44187-024-00186-5","journal-title":"Discover Food"},{"issue":"10","key":"1824_CR89","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1055\/a-1861-2388","volume":"130","author":"J Jiang","year":"2022","unstructured":"Jiang J, Zhao C, Han T, Shan H, Cui G, Li S, Xie Z, Wang J (2022) Advanced glycation end products, bone health, and diabetes mellitus. Exp Clin Endocrinol Diabetes 130(10):671\u2013677. https:\/\/doi.org\/10.1055\/a-1861-2388","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1824_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101208","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH (2021) Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev 65:101208. https:\/\/doi.org\/10.1016\/j.arr.2020.101208","journal-title":"Ageing Res Rev"},{"issue":"4\u20135","key":"1824_CR91","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","volume":"32","author":"RS Jope","year":"2007","unstructured":"Jope RS, Yuskaitis CJ, Beurel E (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res 32(4\u20135):577\u2013595. https:\/\/doi.org\/10.1007\/s11064-006-9128-5","journal-title":"Neurochem Res"},{"issue":"July","key":"1824_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102415","volume":"100","author":"MB Kale","year":"2024","unstructured":"Kale MB, Bhondge HM, Wankhede NL, Shende PV, Thanekaer RP, Aglawe MM, Rahangdale SR, Taksande BG, Pandit SB, Upaganlawar AB, Umekar MJ, Kopalli SR, Koppula S (2024) Navigating the intersection: diabetes and Alzheimer\u2019s intertwined relationship. Ageing Res Rev 100(July):102415. https:\/\/doi.org\/10.1016\/j.arr.2024.102415","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1824_CR93","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","volume":"1863","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Thirumala V, Reddy PH (2017) Is Alzheimer\u2019s disease a type 3 diabetes? A critical appraisal. Biochim Biophys Acta Mol Basis Dis 1863(5):1078\u20131089. https:\/\/doi.org\/10.1016\/j.bbadis.2016.08.018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1824_CR94","doi-asserted-by":"publisher","unstructured":"Karati D, Meur S, Roy S, Mukherjee S, Debnath B, Jha SK, Sarkar BK, Naskar S, Ghosh P (2024) Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer\u2019s disease. Naunyn-Schmiedeberg\u2019s Archives Pharmacol 3(0123456789). https:\/\/doi.org\/10.1007\/s00210-024-03500-1","DOI":"10.1007\/s00210-024-03500-1"},{"issue":"64","key":"1824_CR95","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/EBC20200041","volume":"3","author":"M Katan","year":"2020","unstructured":"Katan M, Cockcroft S (2020) Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane. Essays Biochem 64(3):513\u2013531. https:\/\/doi.org\/10.1042\/EBC20200041","journal-title":"Essays Biochem"},{"issue":"4","key":"1824_CR96","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.pharep.2018.01.008","volume":"70","author":"I Kazkayasi","year":"2018","unstructured":"Kazkayasi I, Burul-Bozkurt N, Ismail MAM, Merino-Serrais P, Pekiner C, Cedazo-Minguez A, Uma S (2018) Insulin deprivation decreases insulin degrading enzyme levels in primary cultured cortical neurons and in the cerebral cortex of rats with streptozotocin-induced diabetes. Pharmacol Rep 70(4):677\u2013683. https:\/\/doi.org\/10.1016\/j.pharep.2018.01.008","journal-title":"Pharmacol Rep"},{"key":"1824_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252211955","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, Kontek R (2024) Alzheimer\u2019s disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252211955","journal-title":"Int J Mol Sci"},{"key":"1824_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094615","author":"TM Ke","year":"2024","unstructured":"Ke TM, Lophatananon A, Muir KR (2024) Strengthening the evidence for a causal link between type 2 diabetes mellitus and pancreatic cancer: insights from two-sample and multivariable Mendelian randomization. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25094615","journal-title":"Int J Mol Sci"},{"issue":"50","key":"1824_CR99","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0912793107","volume":"107","author":"E Kickstein","year":"2010","unstructured":"Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, K\u00f6hler A, Glossmann H, Schneider R, Sutherland C, Schweiger S (2010) Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci U S A 107(50):21830\u201321835. https:\/\/doi.org\/10.1073\/pnas.0912793107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1824_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147697","author":"N Kim","year":"2021","unstructured":"Kim N, Lee HJ (2021) Redox-active metal ions and amyloid\u2010degrading enzymes in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22147697","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1824_CR101","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"JM Basak","year":"2009","unstructured":"Basak JM, Holtzman DM (2009) Review the role of apolipoprotein E in Alzheimer \u2019 s disease. Neuron 63(3):287\u2013303. https:\/\/doi.org\/10.1016\/j.neuron.2009.06.026","journal-title":"Neuron"},{"issue":"3","key":"1824_CR102","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026.The","volume":"63","author":"J Kim","year":"2011","unstructured":"Kim J, Basak JM, Holtzman DM (2011) 85027E Directional Bridge Manual 2.pdf. Neuron 63(3):287\u2013303. https:\/\/doi.org\/10.1016\/j.neuron.2009.06.026.The","journal-title":"Neuron"},{"key":"1824_CR103","doi-asserted-by":"publisher","unstructured":"Kitazawa M, Oddo S, Yamasaki TR, Green KN, Laferla FM (2005) Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer \u2019 s Disease. 25(39), 8843\u20138853. https:\/\/doi.org\/10.1523\/JNEUROSCI.2868-05.2005","DOI":"10.1523\/JNEUROSCI.2868-05.2005"},{"key":"1824_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1824_CR105","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10522-015-9569-9","volume":"16","author":"EG Kochkina","year":"2015","unstructured":"Kochkina EG, Plesneva SA, Vasilev DS, Zhuravin IA, Turner AJ, Nalivaeva NN (2015) Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues. Biogerontology 16(4):473\u2013484. https:\/\/doi.org\/10.1007\/s10522-015-9569-9","journal-title":"Biogerontology"},{"issue":"2","key":"1824_CR106","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","volume":"31","author":"AM Koenig","year":"2017","unstructured":"Koenig AM, Mechanic-hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE (2017) Effects of the insulin sensitizer metformin in Alzheimer disease pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis Assoc Disord 31(2):107\u2013113 . https:\/\/doi.org\/10.1097\/WAD.0000000000000202","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1824_CR107","doi-asserted-by":"publisher","unstructured":"Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472(9):1299\u20131343 https:\/\/doi.org\/10.1007\/s00424-020-02441-x","DOI":"10.1007\/s00424-020-02441-x"},{"issue":"12","key":"1824_CR108","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/jphp.12148","volume":"65","author":"J Kosaraju","year":"2013","unstructured":"Kosaraju J, Murthy V, Khatwal RB, Dubala A, Chinni S, Muthureddy Nataraj SK, Basavan D (2013) Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer\u2019s disease. J Pharm Pharmacol 65(12):1773\u20131784. https:\/\/doi.org\/10.1111\/jphp.12148","journal-title":"J Pharm Pharmacol"},{"key":"1824_CR109","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61373","author":"D Kothandan","year":"2024","unstructured":"Kothandan D, Singh DS, Yerrakula G, D B, N P, Santhana Sophia B V, A R, Ramya VG S, S K, M J (2024) Advanced glycation end products-induced Alzheimer\u2019s disease and its novel therapeutic approaches: a comprehensive review. Cureus. https:\/\/doi.org\/10.7759\/cureus.61373","journal-title":"Cureus"},{"issue":"11","key":"1824_CR110","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","volume":"19","author":"WC Kreisl","year":"2020","unstructured":"Kreisl WC, Kim M, Coughlin JM, Henter ID, Owen DR, Innis RB (2020) Review PET imaging of neuroinflammation in neurological disorders. Lancet Neurol 19(11):940\u2013950. https:\/\/doi.org\/10.1016\/S1474-4422(20)30346-X","journal-title":"Lancet Neurol"},{"issue":"6","key":"1824_CR111","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco MF, Sepulveda J, Kopetsky G, Rebeck GW (2021) Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia 69(6):1478\u20131493. https:\/\/doi.org\/10.1002\/glia.23974","journal-title":"Glia"},{"key":"1824_CR112","doi-asserted-by":"publisher","unstructured":"Laurent C, Bu L, Blum D (2018) ScienceDirect Tau and neuroinflammation: What impact for Alzheimer \u2019 s Disease and Tauopathies ? 1. https:\/\/doi.org\/10.1016\/j.bj.2018.01.003","DOI":"10.1016\/j.bj.2018.01.003"},{"key":"1824_CR113","doi-asserted-by":"publisher","unstructured":"Lee DC, Rizer J, Selenica MB, Reid P, Kraft C, Johnson A, Blair L, Gordon MN, Dickey CA, Morgan D (2010) LPS- induced inflammation exacerbates phospho- tau pathology in rTg4510 mice. J Neuroinflammation 7:56. https:\/\/doi.org\/10.1186\/1742-2094-7-56","DOI":"10.1186\/1742-2094-7-56"},{"issue":"18","key":"1824_CR114","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","volume":"81","author":"C Lennicke","year":"2021","unstructured":"Lennicke C, Cochem\u00e9 HM (2021) Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell 81(18):3691\u20133707. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.018","journal-title":"Mol Cell"},{"key":"1824_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101245","volume":"52","author":"D LeRoith","year":"2021","unstructured":"LeRoith D, Holly JMP, Forbes BE (2021) Insulin-like growth factors: ligands, binding proteins, and receptors. Mol Metab 52:101245. https:\/\/doi.org\/10.1016\/j.molmet.2021.101245","journal-title":"Mol Metab"},{"key":"1824_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010403","author":"W Li","year":"2025","unstructured":"Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, Jiang L, Xu S, Huang L (2025) Roles of the receptor for advanced glycation end products and its ligands in the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26010403","journal-title":"Int J Mol Sci"},{"key":"1824_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2021.503437","volume":"874","author":"JEBF Lima","year":"2022","unstructured":"Lima JEBF, Moreira NCS, Sakamoto-Hojo ET (2022) Mechanisms underlying the pathophysiology of type 2 diabetes: from risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutat Res-Genet Toxicol Environ Mutagen 874:503437. https:\/\/doi.org\/10.1016\/j.mrgentox.2021.503437","journal-title":"Mutat Res-Genet Toxicol Environ Mutagen"},{"key":"1824_CR118","doi-asserted-by":"publisher","unstructured":"Limantoro J, de Liyis BG, Sutedja JC (2023) Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition. Egypt J Neurol Psychiatry Neurosurg 59(1). https:\/\/doi.org\/10.1186\/s41983-023-00751-2","DOI":"10.1186\/s41983-023-00751-2"},{"key":"1824_CR119","doi-asserted-by":"crossref","unstructured":"Liu Y, Liu F, Grundke-iqbal I, Iqbal K, Gong C (2011) Deficient brain insulin signalling pathway in Alzheimer \u2019 s disease. May, 54\u201362","DOI":"10.1002\/path.2912"},{"issue":"PB","key":"1824_CR120","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2013.10.052","volume":"557","author":"F Liu","year":"2013","unstructured":"Liu F, Wang Y, Yan M, Zhang L, Pang T, Liao H (2013) Glimepiride attenuates A\u03b2 production via suppressing BACE1 activity in cortical neurons. Neurosci Lett 557(PB):90\u201394. https:\/\/doi.org\/10.1016\/j.neulet.2013.10.052","journal-title":"Neurosci Lett"},{"key":"1824_CR121","doi-asserted-by":"publisher","unstructured":"Llori\u00e1n-Salvador M, Cabeza-Fern\u00e1ndez S, Gomez-Sanchez JA, de la Fuente AG (2024) Glial cell alterations in diabetes-induced neurodegeneration. Cell Mol Life Sci 81(1). https:\/\/doi.org\/10.1007\/s00018-023-05024-y","DOI":"10.1007\/s00018-023-05024-y"},{"key":"1824_CR122","doi-asserted-by":"publisher","unstructured":"Lozupone M, Panza F (2024) Impact of apolipoprotein E isoforms on sporadic Alzheimer\u2019s disease: beyond the role of amyloid beta. Neural Regen Res 19(1):80\u201383. https:\/\/doi.org\/10.4103\/1673-5374.375316","DOI":"10.4103\/1673-5374.375316"},{"issue":"2","key":"1824_CR123","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2217\/14796708.4.2.167","volume":"4","author":"LF Lue","year":"2009","unstructured":"Lue LF, Walker DG, Jacobson S, Sabbagh M (2009) Receptor for advanced glycation end products: its role in Alzheimer\u2019s disease and other neurological diseases. Future Neurol 4(2):167\u2013177. https:\/\/doi.org\/10.2217\/14796708.4.2.167","journal-title":"Future Neurol"},{"issue":"10","key":"1824_CR124","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1517\/14728222.12.10.1265","volume":"12","author":"K MacAulay","year":"2008","unstructured":"MacAulay K, Woodgett JR (2008) Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of type 2 diabetes. Expert Opin Ther Targets 12(10):1265\u20131274. https:\/\/doi.org\/10.1517\/14728222.12.10.1265","journal-title":"Expert Opin Ther Targets"},{"key":"1824_CR125","doi-asserted-by":"publisher","unstructured":"Maeba R, Araki A, Fujiwara Y (2018) Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers. In Advances in Clinical Chemistry (Vol. 87). Elsevier Ltd. https:\/\/doi.org\/10.1016\/bs.acc.2018.08.001","DOI":"10.1016\/bs.acc.2018.08.001"},{"key":"1824_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119328","author":"MO Mahgoub","year":"2023","unstructured":"Mahgoub MO, Ali II, Adeghate JO, Tekes K, Kal\u00e1sz H, Adeghate EA (2023) An update on the molecular and cellular basis of pharmacotherapy in type 2 diabetes mellitus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119328","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1824_CR127","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.3390\/cimb46060327","volume":"46","author":"P Ma\u0142kowska","year":"2024","unstructured":"Ma\u0142kowska P (2024) Positive effects of physical activity on insulin signaling. Curr Issues Mol Biol 46(6):5467\u20135487. https:\/\/doi.org\/10.3390\/cimb46060327","journal-title":"Curr Issues Mol Biol"},{"issue":"13","key":"1824_CR128","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer \u2019 s disease\u202f: implications for neuronal damage. Hum Mol Genet 20(13):2495\u20132509. https:\/\/doi.org\/10.1093\/hmg\/ddr139","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1824_CR129","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/oxygen2020006","volume":"2","author":"G Martemucci","year":"2022","unstructured":"Martemucci G, Costagliola C, Mariano M, D\u2019andrea L, Napolitano P, D\u2019Alessandro AG (2022) Free radical properties, source and targets, antioxidant consumption and health. Oxygen 2(2):48\u201378. https:\/\/doi.org\/10.3390\/oxygen2020006","journal-title":"Oxygen"},{"issue":"8","key":"1824_CR130","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu C, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM (2022) Review ApoE cascade hypothesis in the pathogenesis of Alzheimer \u2019 s disease and related dementias. Neuron 110(8):1304\u20131317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","journal-title":"Neuron"},{"key":"1824_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2021","unstructured":"Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190:108352. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108352","journal-title":"Neuropharmacology"},{"issue":"1","key":"1824_CR132","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgn250","volume":"30","author":"S Maynard","year":"2009","unstructured":"Maynard S, Schurman SH, Harboe C, Souza-pinto NC, De, \u00c3 VAB (2009) Base excision repair oxidative DNA damage association cancer aging 30(1):2\u201310. https:\/\/doi.org\/10.1093\/carcin\/bgn250","journal-title":"Base excision repair oxidative DNA damage association cancer aging"},{"key":"1824_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101213","author":"O Mazuryk","year":"2024","unstructured":"Mazuryk O, Gurgul I, Oszajca M, Polaczek J, Kieca K, Bieszczad-\u017bak E, Martyka T, Stochel G (2024) Nitric oxide signaling and sensing in age-related diseases. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13101213","journal-title":"Antioxidants"},{"key":"1824_CR134","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuropharm.2014.07.015","volume":"86","author":"PL McClean","year":"2014","unstructured":"McClean PL, H\u00f6lscher C (2014) Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer\u2019s disease. Neuropharmacology 86:241\u2013258. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.07.015","journal-title":"Neuropharmacology"},{"key":"1824_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflamm 5:1\u201313. https:\/\/doi.org\/10.1186\/1742-2094-5-45","journal-title":"J Neuroinflamm"},{"key":"1824_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113076","volume":"323","author":"EC McNay","year":"2020","unstructured":"McNay EC, Pearson-Leary J (2020) GluT4: a central player in hippocampal memory and brain insulin resistance. Exp Neurol 323:113076. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113076","journal-title":"Exp Neurol"},{"issue":"5","key":"1824_CR137","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","volume":"17","author":"R Medeiros","year":"2011","unstructured":"Medeiros R, Baglietto-Vargas D, Laferla FM (2011) The role of tau in Alzheimer\u2019s disease and related disorders. CNS Neurosci Ther 17(5):514\u2013524. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00177.x","journal-title":"CNS Neurosci Ther"},{"key":"1824_CR138","doi-asserted-by":"publisher","unstructured":"MinersJS, Barua N, Kehoe PG, Gill S, Love S (2017) A\u03b2-Degrading Enzymes: Potential for Treatment of Alzheimer Disease. J Neuropathol Exp Neurol 70(11):944\u2013959. https:\/\/doi.org\/10.1097\/NEN.0b013e3182345e46","DOI":"10.1097\/NEN.0b013e3182345e46"},{"issue":"2","key":"1824_CR139","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.dsx.2016.01.021","volume":"10","author":"K Mittal","year":"2016","unstructured":"Mittal K, Katare DP (2016) Shared links between type 2 diabetes mellitus and Alzheimer\u2019s disease: a review. Diabetes Metab Syndr Clin Res Rev 10(2):S144\u2013S149. https:\/\/doi.org\/10.1016\/j.dsx.2016.01.021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"6","key":"1824_CR140","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1043-2760(00)00272-1","volume":"11","author":"DE Moller","year":"2000","unstructured":"Moller DE (2000) Potential role of TNF-\u03b1 in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11(6):212\u2013217. https:\/\/doi.org\/10.1016\/S1043-2760(00)00272-1","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1824_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-021-01442-z","volume":"21","author":"P Mone","year":"2022","unstructured":"Mone P, Gambardella J, Lombardi A, Pansini A, De Gennaro S, Leo AL, Famiglietti M, Marro A, Morgante M, Frullone S, De Luca A, Santulli G (2022) Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults. Cardiovasc Diabetol 21(1):1\u20136. https:\/\/doi.org\/10.1186\/s12933-021-01442-z","journal-title":"Cardiovasc Diabetol"},{"key":"1824_CR142","doi-asserted-by":"publisher","unstructured":"Montgomery MK, Turner N (2015) Mitochondrial dysfunction and insulin resistance: an update. https:\/\/doi.org\/10.1530\/EC-14-0092","DOI":"10.1530\/EC-14-0092"},{"key":"1824_CR143","doi-asserted-by":"publisher","unstructured":"Mosconi L, Pupi A, Leon MJD (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer \u2019 s disease. Ann N Y Acad Sci. https:\/\/doi.org\/10.1196\/annals.1427.007","DOI":"10.1196\/annals.1427.007"},{"issue":"1","key":"1824_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2021.0246","volume":"24","author":"M Munshi","year":"2022","unstructured":"Munshi M, Slyne C, Davis D, Michals A, Sifre K, Dewar R, Atakov-Castillo A, Toschi E (2022) Use of technology in older adults with type 1 diabetes: clinical characteristics and glycemic metrics. Diabetes Technol Ther 24(1):1\u20139. https:\/\/doi.org\/10.1089\/dia.2021.0246","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"1824_CR145","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/febs.16151","volume":"289","author":"R Muraleedharan","year":"2022","unstructured":"Muraleedharan R, Dasgupta B (2022) AMPK in the brain: its roles in glucose and neural metabolism. FEBS J 289(8):2247\u20132262. https:\/\/doi.org\/10.1111\/febs.16151","journal-title":"FEBS J"},{"issue":"1","key":"1824_CR146","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.sjbs.2014.05.003","volume":"22","author":"G Mushtaq","year":"2015","unstructured":"Mushtaq G, Khan JA, Kumosani TA, Kamal MA (2015) Alzheimer\u2019s disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci 22(1):4\u201313. https:\/\/doi.org\/10.1016\/j.sjbs.2014.05.003","journal-title":"Saudi J Biol Sci"},{"issue":"12","key":"1824_CR147","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.4239\/wjd.v12.i12.2036","volume":"12","author":"A Nakhleh","year":"2021","unstructured":"Nakhleh A, Shehadeh N (2021) Hypoglycemia in diabetes: an update on pathophysiology, treatment, and prevention. World J Diabetes 12(12):2036\u20132049. https:\/\/doi.org\/10.4239\/wjd.v12.i12.2036","journal-title":"World J Diabetes"},{"issue":"2","key":"1824_CR148","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/156720508783954785","volume":"5","author":"N Nalivaeva","year":"2008","unstructured":"Nalivaeva N, Fisk L, Belyaev N, Turner A (2008) Amyloid-degrading enzymes as therapeutic targets in Alzheimers disease. Curr Alzheimer Res 5(2):212\u2013224. https:\/\/doi.org\/10.2174\/156720508783954785","journal-title":"Curr Alzheimer Res"},{"key":"1824_CR149","doi-asserted-by":"publisher","unstructured":"NapolitanoG, Fasciolo G, Venditti P (2021) Mitochondrial Management of Reactive Oxygen Species. Antioxidants (Basel) 10(11):1824. https:\/\/doi.org\/10.3390\/antiox10111824","DOI":"10.3390\/antiox10111824"},{"issue":"6","key":"1824_CR150","doi-asserted-by":"publisher","first-page":"596","DOI":"10.4062\/biomolther.2021.122","volume":"29","author":"V Natesan","year":"2021","unstructured":"Natesan V, Kim SJ (2021) Lipid metabolism, disorders and therapeutic drugs \u2013 review. Biomol Ther Seoul 29(6):596\u2013604. https:\/\/doi.org\/10.4062\/biomolther.2021.122","journal-title":"Biomol Ther Seoul"},{"key":"1824_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071011","author":"C Nedeva","year":"2021","unstructured":"Nedeva C (2021) Inflammation and cell death of the innate and adaptive immune system during sepsis. Biomolecules. https:\/\/doi.org\/10.3390\/biom11071011","journal-title":"Biomolecules"},{"issue":"1","key":"1824_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-30487-6","volume":"8","author":"A Ng","year":"2018","unstructured":"Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, Ho RC (2018) IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis. Sci Rep 8(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-018-30487-6","journal-title":"Sci Rep"},{"key":"1824_CR153","doi-asserted-by":"publisher","unstructured":"Ninomiya T (2019) Epidemiological evidence of the relationship between diabetes and dementia. In Advances in Experimental Medicine and Biology (Vol. 1128, pp. 13\u201325). Springer New York LLC. https:\/\/doi.org\/10.1007\/978-981-13-3540-2_2","DOI":"10.1007\/978-981-13-3540-2_2"},{"key":"1824_CR154","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"1824_CR155","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3103\/S009639252460100X","volume":"79","author":"GYF Orcid","year":"2024","unstructured":"Orcid GYF (2024) Photosensitized reactions of oxidative damage to biomolecules\u202f: role in genotoxic and cytotoxic processes. Moscow Univ Biol Sci Bull 79(3):115\u2013129. https:\/\/doi.org\/10.3103\/S009639252460100X","journal-title":"Moscow Univ Biol Sci Bull"},{"key":"1824_CR156","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuropharm.2015.09.030","volume":"101","author":"C Osborne","year":"2016","unstructured":"Osborne C, West E, Nolan W, McHale-Owen H, Williams A, Bate C (2016) Glimepiride protects neurons against amyloid-\u03b2-induced synapse damage. Neuropharmacology 101:225\u2013236. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.030","journal-title":"Neuropharmacology"},{"key":"1824_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110708","volume":"131","author":"S Padhi","year":"2020","unstructured":"Padhi S, Nayak AK, Behera A (2020) Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother 131:110708. https:\/\/doi.org\/10.1016\/j.biopha.2020.110708","journal-title":"Biomed Pharmacother"},{"issue":"0","key":"1824_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddx405","volume":"0","author":"SS Pappas","year":"2018","unstructured":"Pappas SS, Liang C, Kim S, Rivera CO, Dauer WT (2018) TorsinA dysfunction causes persistent neuronal nuclear pore defects. Hum Mol Genet 0(0):1\u201314. https:\/\/doi.org\/10.1093\/hmg\/ddx405","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1824_CR159","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev 104(1):103\u2013197. https:\/\/doi.org\/10.1152\/physrev.00030.2022","journal-title":"Physiol Rev"},{"key":"1824_CR160","doi-asserted-by":"publisher","unstructured":"Pivovarova O, H\u00f6hn A, Grune T, Pfeiffer AFH (2016a) Annals of Medicine Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer \u2019 s disease ? 3890. https:\/\/doi.org\/10.1080\/07853890.2016.1197416","DOI":"10.1080\/07853890.2016.1197416"},{"issue":"8","key":"1824_CR161","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","volume":"48","author":"O Pivovarova","year":"2016","unstructured":"Pivovarova O, H\u00f6hn A, Grune T, Pfeiffer AFH, Rudovich N (2016) Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer\u2019s disease? Ann Med 48(8):614\u2013624. https:\/\/doi.org\/10.1080\/07853890.2016.1197416","journal-title":"Ann Med"},{"key":"1824_CR162","doi-asserted-by":"publisher","unstructured":"Polis B, Samson AO (2019) A New Perspective on Alzheimer \u2019 s Disease as a Brain Expression of a Complex Metabolic Disorder. In: Wisniewski T, editor. Alzheimer\u2019s Disease. Brisbane (AU): Codon Publications; Chap. 1, 1\u201322. https:\/\/doi.org\/10.15586\/alzheimersdisease.2019.ch1","DOI":"10.15586\/alzheimersdisease.2019.ch1"},{"key":"1824_CR163","doi-asserted-by":"publisher","unstructured":"Potenza MA, Sgarra L, Desantis V, Nacci C, Montagnani M (2021) Diabetes and alzheimer\u2019s disease: might mitochondrial dysfunction help deciphering the common path? Antioxidants. https:\/\/doi.org\/10.3390\/antiox10081257","DOI":"10.3390\/antiox10081257"},{"issue":"4","key":"1824_CR164","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","volume":"25","author":"A Prakash","year":"2014","unstructured":"Prakash A, Kumar A (2014) Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of \u03b2-amyloid animal model of Alzheimer\u2019s disease. Neurotox Res 25(4):335\u2013347. https:\/\/doi.org\/10.1007\/s12640-013-9437-9","journal-title":"Neurotox Res"},{"key":"1824_CR165","doi-asserted-by":"crossref","unstructured":"Albajy MA, Mihailescu DF (2024) MANAGEMENT OF TYPE 2 DIABETES POST\u0118POWANIE W CUKRZYCY TYPU 2. Health Prob Civil 18(4), 421\u2013439.","DOI":"10.5114\/hpc.2024.136467"},{"issue":"24","key":"1824_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms252413570","volume":"25","author":"M Radziszewski","year":"2024","unstructured":"Radziszewski M, Galus R, \u0141uszczy\u0144ski K, Winiarski S, W\u0105sowski D, Malejczyk J, W\u0142odarski P, \u015acie\u017cy\u0144ska A (2024) The RAGE pathway in skin pathology development: a comprehensive review of its role and therapeutic potential. Int J Mol Sci 25(24):1\u201330. https:\/\/doi.org\/10.3390\/ijms252413570","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1824_CR167","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/diabetology5010004","volume":"5","author":"M Randv\u00e4li","year":"2024","unstructured":"Randv\u00e4li M, Toomsoo T, \u0160teinmiller J (2024) The main risk factors in type 2 diabetes for cognitive dysfunction, depression, and psychosocial problems: a systematic review. Diabetology 5(1):40\u201359. https:\/\/doi.org\/10.3390\/diabetology5010004","journal-title":"Diabetology"},{"key":"1824_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2025.100125","volume":"12","author":"G Reid","year":"2025","unstructured":"Reid G, Sargent B, Bauermeister S, Adler A, Koychev I (2025) A systematic review of in vivo brain insulin resistance biomarkers in humans. Biomark Neuropsychiatry 12:100125. https:\/\/doi.org\/10.1016\/j.bionps.2025.100125","journal-title":"Biomark Neuropsychiatry"},{"issue":"6","key":"1824_CR169","doi-asserted-by":"publisher","first-page":"745","DOI":"10.4239\/wjd.v12.i6.745","volume":"12","author":"M Rojas","year":"2021","unstructured":"Rojas M, Ch\u00e1vez-Castillo M, Bautista J, Ortega \u00c1, Nava M, Salazar J, D\u00edaz-Camargo E, Medina O, Rojas-Quintero J, Berm\u00fadez V (2021) Alzheimer\u2019s disease and type 2 diabetes mellitus: pathophysiologic and pharmacotherapeutics links. World J Diabetes 12(6):745\u2013766. https:\/\/doi.org\/10.4239\/wjd.v12.i6.745","journal-title":"World J Diabetes"},{"issue":"July","key":"1824_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101998","volume":"88","author":"S Roy","year":"2024","unstructured":"Roy S, Pokharel P, Piganelli JD (2024) Decoding the immune dance: unraveling the interplay between beta cells and type 1 diabetes. Mol Metab 88(July):101998. https:\/\/doi.org\/10.1016\/j.molmet.2024.101998","journal-title":"Mol Metab"},{"issue":"1","key":"1824_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369101","volume":"24","author":"S Sadigh-Eteghad","year":"2015","unstructured":"Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J (2015) Amyloid-beta: a crucial factor in Alzheimer\u2019s disease. Med Princ Pract 24(1):1\u201310. https:\/\/doi.org\/10.1159\/000369101","journal-title":"Med Princ Pract"},{"issue":"July","key":"1824_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112430","volume":"229","author":"T Sarabhai","year":"2025","unstructured":"Sarabhai T, Zingel R, Bohlken J, Kostev K (2025) Association between SGLT2 inhibitor therapy and prolonged dementia-free survival in older adults with type 2 diabetes: a retrospective cohort study from Germany. Diabetes Res Clin Pract 229(July):112430. https:\/\/doi.org\/10.1016\/j.diabres.2025.112430","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1824_CR173","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1464-5491.2005.01566.x","volume":"22","author":"S Schinner","year":"2005","unstructured":"Schinner S, Scherbaum WA, Bornstein SR, Barthel A (2005) Molecular mechanisms of insulin resistance. Diabet Med 22(6):674\u2013682. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01566.x","journal-title":"Diabet Med"},{"issue":"1","key":"1824_CR174","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jimd.12083","volume":"43","author":"M Schrader","year":"2020","unstructured":"Schrader M, Kamoshita M, Islinger M (2020) Organelle interplay\u2014peroxisome interactions in health and disease. J Inherit Metab Dis 43(1):71\u201389. https:\/\/doi.org\/10.1002\/jimd.12083","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1824_CR175","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-2012-111661","volume":"30","author":"JL Searcy","year":"2012","unstructured":"Searcy JL, Phelps JT, Pancani T, Kadish I, Popovic J, Anderson KL, Beckett TL, Murphy MP, Chen KC, Blalock EM, Landfield PW, Porter NM, Thibault O (2012) Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 30(4):943\u2013961. https:\/\/doi.org\/10.3233\/JAD-2012-111661","journal-title":"J Alzheimers Dis"},{"key":"1824_CR176","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.trci.2019.08.003","volume":"5","author":"V Senanayake","year":"2019","unstructured":"Senanayake V, Goodenowe DB (2019) Plasmalogen deficiency and neuropathology in Alzheimer\u2019s disease: causation or coincidence? Alzheimer\u2019s Dementia: Translational Res Clin Interventions 5:524\u2013532. https:\/\/doi.org\/10.1016\/j.trci.2019.08.003","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"issue":"1","key":"1824_CR177","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5455\/bcp.20120112064639","volume":"22","author":"V Sharma","year":"2012","unstructured":"Sharma V, Thakur V, Bhandari S, Singh SN, Guleria R (2012) Tumor necrosis factor and Alzheimer\u2019s disease: a cause and consequence relationship. Klinik Psikofarmakoloji Bulteni 22(1):86\u201397. https:\/\/doi.org\/10.5455\/bcp.20120112064639","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"key":"1824_CR178","doi-asserted-by":"publisher","unstructured":"Shen X, Feng R, Zhou R, Zhang C, Liu K, Wang S, Shen X, Feng R, Zhou R, Zhang C, Liu K (2024) Ceramide as a Promising Tool for Diagnosis and Treatment of Clinical Diseases: A Review of Recent Advances Ceramide As a Promising Tool for Diagnosis and Treatment of Clinical Diseases : A Review of Recent Advances. 0\u201330. https:\/\/doi.org\/10.20944\/preprints202412.1680.v1","DOI":"10.20944\/preprints202412.1680.v1"},{"issue":"22","key":"1824_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms252212311","volume":"25","author":"MG Sighencea","year":"2024","unstructured":"Sighencea MG, Popescu R, Trifu SC (2024) From fundamentals to innovation in Alzheimer\u2019s disease: molecular findings and revolutionary therapies. Int J Mol Sci 25(22):1\u201349. https:\/\/doi.org\/10.3390\/ijms252212311","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1824_CR180","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/1873-3468.12902","volume":"592","author":"R Stefanatos","year":"2018","unstructured":"Stefanatos R, Sanz A (2018) The role of mitochondrial ROS in the aging brain. FEBS Lett 592(5):743\u2013758. https:\/\/doi.org\/10.1002\/1873-3468.12902","journal-title":"FEBS Lett"},{"key":"1824_CR181","doi-asserted-by":"publisher","unstructured":"Su M, Naderi K, Samson N, Youssef I, F\u00fcl\u00f6p L, Bozso Z, Laroche S, Delatour B, Davis S, Davis S (2019a) Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology. Mol Neurobiol 56(8):5815\u20135834. https:\/\/doi.org\/10.1007\/s12035-019-1475-8","DOI":"10.1007\/s12035-019-1475-8"},{"key":"1824_CR182","doi-asserted-by":"publisher","unstructured":"Su XQ, Wang J, Sinclair AJ (2019b) Plasmalogens and Alzheimer\u2019s disease: a review. Lipids Health Dis18(1):100. https:\/\/doi.org\/10.1186\/s12944-019-1044-1","DOI":"10.1186\/s12944-019-1044-1"},{"key":"1824_CR183","doi-asserted-by":"publisher","unstructured":"Subtirelu RC, Teichner EM, Su Y, Al-Daoud O, Patel M, Patil S, Writer M, Werner T, Revheim ME, H\u00f8ilund-Carlsen PF, Alavi A (2023) Aging and cerebral glucose metabolism: 18F-FDG-PET\/CT reveals distinct global and regional metabolic changes in healthy patients. Life. https:\/\/doi.org\/10.3390\/life13102044","DOI":"10.3390\/life13102044"},{"key":"1824_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102775","volume":"109","author":"VV Sugandhi","year":"2025","unstructured":"Sugandhi VV, Gadhave DG, Ugale AR, Kulkarni N, Nangare SN, Patil HP, Rath S, Saxena R, Lavate A, Patel AT, Jadhav A, Paudel KR (2025) Advances in Alzheimer\u2019s therapy: exploring neuropathological mechanisms to revolutionize the future therapeutic landscape. Ageing Res Rev 109:102775. https:\/\/doi.org\/10.1016\/j.arr.2025.102775","journal-title":"Ageing Res Rev"},{"key":"1824_CR185","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4981814","author":"Y Sun","year":"2020","unstructured":"Sun Y, Ma C, Sun H, Wang H, Peng W, Zhou Z, Wang H, Pi C, Shi Y, He X (2020) Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease. J Diabetes Res. https:\/\/doi.org\/10.1155\/2020\/4981814","journal-title":"J Diabetes Res"},{"key":"1824_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158142","author":"L Szablewski","year":"2021","unstructured":"Szablewski L (2021) Brain glucose transporters: role in pathogenesis and potential targets for the treatment of alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22158142","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1824_CR187","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.bja.2019.03.033","volume":"123","author":"K Talbot","year":"2019","unstructured":"Talbot K, Madden VJ, Jones SL, Moseley GL, Town C, Africa S (2019) The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience ? A systematic review. Br J Anaesth 123(2):e263\u2013e272. https:\/\/doi.org\/10.1016\/j.bja.2019.03.033","journal-title":"Br J Anaesth"},{"key":"1824_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115938","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, Cost\u0103chescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation and neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23115938","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1824_CR189","doi-asserted-by":"publisher","first-page":"704","DOI":"10.7326\/L20-0011","volume":"172","author":"S Tian","year":"2020","unstructured":"Tian S, Wu J, Liu JS, Zou BS, Kong LQ (2020) Type 2 diabetes. Ann Intern Med 172(10):704\u2013705. https:\/\/doi.org\/10.7326\/L20-0011","journal-title":"Ann Intern Med"},{"key":"1824_CR190","doi-asserted-by":"crossref","unstructured":"Tilokani L, Nagashima S, Paupe V, Prudent J (2018) Mitochondrial dynamics: overview of molecular mechanisms. 0(May), 341\u2013360","DOI":"10.1042\/EBC20170104"},{"issue":"4","key":"1824_CR191","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J Alzheimer\u2019s Disease 57(4):1105\u20131121. https:\/\/doi.org\/10.3233\/JAD-161088","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"5","key":"1824_CR192","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1007\/s12035-023-03736-7","volume":"61","author":"W Tsering","year":"2024","unstructured":"Tsering W, Prokop S (2024) Neuritic plaques \u2014 gateways to understanding Alzheimer\u2019s disease. Mol Neurobiol 61(5):2808\u20132821. https:\/\/doi.org\/10.1007\/s12035-023-03736-7","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1824_CR193","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12529","volume":"45","author":"M Tzioras","year":"2019","unstructured":"Tzioras M, Davies C, Newman A, Jackson R, Spires-Jones T (2019) Invited review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 45(4):327\u2013346. https:\/\/doi.org\/10.1111\/nan.12529","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1824_CR194","doi-asserted-by":"publisher","unstructured":"Veselov IM, Vinogradova DV, Maltsev AV, Shevtsov PN, Spirkova EA, Bachurin SO, Shevtsova EF (2023) Mitochondria and Oxidative Stress as a Link between Alzheimer\u2019s Disease and Diabetes Mellitus. Int J Mol Sci 24(19). https:\/\/doi.org\/10.3390\/ijms241914450","DOI":"10.3390\/ijms241914450"},{"issue":"4","key":"1824_CR195","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCRESAHA.119.316463","volume":"127","author":"K Veys","year":"2020","unstructured":"Veys K, Fan Z, Ghobrial M, Bouch\u00e9 A, Garc\u00eda-Caballero M, Vriens K, Conchinha NV, Seuwen A, Schlegel F, Gorski T, Crabb\u00e9 M, Gilardoni P, Ardicoglu R, Schaffenrath J, Casteels C, De Smet G, Smolders I, Van Laere K, Abel ED, De Bock K (2020) Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood-brain barrier integrity. Circ Res 127(4):466\u2013482. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316463","journal-title":"Circ Res"},{"key":"1824_CR196","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1386-3","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-015-1386-3","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1824_CR197","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5005\/jp\/books\/11057_43","volume":"18","author":"P Wainwright","year":"2016","unstructured":"Wainwright P (2016) Chemical pathology. Diabetes Prim Care 18(1):12\u201316. https:\/\/doi.org\/10.5005\/jp\/books\/11057_43","journal-title":"Diabetes Prim Care"},{"issue":"1","key":"1824_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0315-7","volume":"14","author":"T Wakabayashi","year":"2019","unstructured":"Wakabayashi T, Yamaguchi K, Matsui K, Sano T, Kubota T, Hashimoto T, Mano A, Yamada K, Matsuo Y, Kubota N, Kadowaki T, Iwatsubo T (2019) Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 14(1):1\u201318. https:\/\/doi.org\/10.1186\/s13024-019-0315-7","journal-title":"Mol Neurodegener"},{"issue":"10","key":"1824_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3(10):1\u201315. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49","journal-title":"Ann Transl Med"},{"issue":"1","key":"1824_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin YL, Liu XZ, Shen P, Zheng YG, Lan XR, Lu CB, Wang JZ (2020) Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 9(1):1\u201313. https:\/\/doi.org\/10.1186\/s40035-020-00189-z","journal-title":"Transl Neurodegener"},{"issue":"11","key":"1824_CR201","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/alz.12538","volume":"18","author":"T Wang","year":"2022","unstructured":"Wang T, Huynh K, Giles C, Mellett NA, Duong T, Nguyen A, Lim WLF, Smith AAT, Olshansky G, Cadby G, Hung J, Hui J, Beilby J, Watts GF, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Meikle PJ (2022) APOE \u03b52 resilience for Alzheimer\u2019s disease is mediated by plasma lipid species: analysis of three independent cohort studies. Alzheimers Dement 18(11):2151\u20132166. https:\/\/doi.org\/10.1002\/alz.12538","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1824_CR202","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70014","volume":"16","author":"R Weinberg Sibony","year":"2024","unstructured":"Weinberg Sibony R, Segev O, Dor S, Raz I (2024) Overview of oxidative stress and inflammation in diabetes. J Diabetes 16(10):e70014. https:\/\/doi.org\/10.1111\/1753-0407.70014","journal-title":"J Diabetes"},{"issue":"12","key":"1824_CR203","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"N Wijesekara","year":"2017","unstructured":"Wijesekara N, Ahrens R, Sabale M, Wu L, Ha K, Verdile G, Fraser PE (2017) Amyloid-b and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J 31(12):5409\u20135418. https:\/\/doi.org\/10.1096\/fj.201700431R","journal-title":"FASEB J"},{"key":"1824_CR204","doi-asserted-by":"crossref","unstructured":"Wium-andersen IK, Osler M, Balslev M, Wium-andersen MK (2022) Psychoneuroendocrinology Diabetes, antidiabetic medications and risk of depression \u2013 A population-based cohort and nested case-control study. 140(March)","DOI":"10.1016\/j.psyneuen.2022.105715"},{"issue":"1","key":"1824_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-019-0289-8","volume":"9","author":"MF Xia","year":"2019","unstructured":"Xia MF, Zhang YZ, Jin K, Lu ZT, Zeng Z, Xiong W (2019) Communication between mitochondria and other organelles: a brand-new perspective on mitochondria in cancer. Cell Biosci 9(1):1\u201319. https:\/\/doi.org\/10.1186\/s13578-019-0289-8","journal-title":"Cell Biosci"},{"key":"1824_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.06.013","author":"J Xie","year":"2013","unstructured":"Xie J, M\u00e9ndez JD, M\u00e9ndez-valenzuela V (2013) Full length RAGE Full length RAGE. Cell Signal. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.013","journal-title":"Cell Signal"},{"issue":"3","key":"1824_CR207","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3233\/JAD-130584","volume":"37","author":"H Xiong","year":"2013","unstructured":"Xiong H, Zheng C, Wang J, Song J, Zhao G, Shen H, Deng Y (2013) The neuroprotection of liraglutide on alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice. J Alzheimers Dis 37(3):623\u2013635. https:\/\/doi.org\/10.3233\/JAD-130584","journal-title":"J Alzheimers Dis"},{"key":"1824_CR208","doi-asserted-by":"publisher","unstructured":"Xu F, Shi J (2025) Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer \u2019 s disease. https:\/\/doi.org\/10.1177\/13872877241307404","DOI":"10.1177\/13872877241307404"},{"issue":"4S_Part_8","key":"1824_CR209","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jalz.2011.05.839","volume":"7","author":"K Yaffe","year":"2011","unstructured":"Yaffe K, Lindquist K, Schwartz A, Vitartas C, Vittinghoff E, Satterfield S, Simonsick E, Launer L, Rosano C, Cauley J, Harris T (2011) O2-01\u201007: advanced glycation endproduct level, diabetes and accelerated cognitive aging. Alzheimers Dement 7(4S_Part_8):1351\u20131356. https:\/\/doi.org\/10.1016\/j.jalz.2011.05.839","journal-title":"Alzheimers Dement"},{"key":"1824_CR210","doi-asserted-by":"publisher","unstructured":"YaffeK, Sawaya G, Lieberburg I, Grady D (2015) Estrogen Therapy Postmenopausal Women: Effects on Cognitive Function and Dement. JAMA 279(9):688\u201395. https:\/\/doi.org\/10.1001\/jama.279.9.688","DOI":"10.1001\/jama.279.9.688"},{"issue":"3","key":"1824_CR211","doi-asserted-by":"publisher","first-page":"641","DOI":"10.21608\/jbaar.2024.382794","volume":"10","author":"AA Yameny","year":"2024","unstructured":"Yameny AA (2024) Diabetes mellitus overview 2024. J Bioscience Appl Res 10(3):641\u2013645. https:\/\/doi.org\/10.21608\/jbaar.2024.382794","journal-title":"J Bioscience Appl Res"},{"issue":"6","key":"1824_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166726","volume":"1869","author":"Z Yan","year":"2023","unstructured":"Yan Z, Cao X, Sun S, Sun B, Gao J (2023) Inhibition of GSK3B phosphorylation improves glucose and lipid metabolism disorder. Biochimica et Biophysica Acta - Molecular Basis of Disease 1869(6):166726. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166726","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"issue":"1","key":"1824_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-022-00828-0","volume":"12","author":"D Yang","year":"2022","unstructured":"Yang D, Wang X, Zhang L, Fang Y, Zheng Q, Liu X, Yu W, Chen S, Ying J, Hua F (2022) Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases. Cell Biosci 12(1):1\u201316. https:\/\/doi.org\/10.1186\/s13578-022-00828-0","journal-title":"Cell Biosci"},{"key":"1824_CR214","doi-asserted-by":"publisher","unstructured":"Ye M, Yang Q, Zhang L, Song H, Fu Q, Qian J, Xie H, Yuan A (2024) Effect of hypoglycemic events on cognitive function in individuals with type 2 diabetes mellitus: a dose\u2013response meta-analysis. Front Neurol 15(August). https:\/\/doi.org\/10.3389\/fneur.2024.1394499","DOI":"10.3389\/fneur.2024.1394499"},{"issue":"8","key":"1824_CR215","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1073\/pnas.0511154103","volume":"103","author":"T Yu","year":"2006","unstructured":"Yu T, Robotham JL, Yoon Y (2006) Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A 103(8):2653\u20132658. https:\/\/doi.org\/10.1073\/pnas.0511154103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"April","key":"1824_CR216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2022.853911","volume":"16","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhao J, Quan Z, Li H, Qing H (2022) Mitochondria and other organelles in neural development and their potential as therapeutic targets in neurodegenerative diseases. Front Neurosci 16(April):1\u201318. https:\/\/doi.org\/10.3389\/fnins.2022.853911","journal-title":"Front Neurosci"},{"key":"1824_CR217","doi-asserted-by":"publisher","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. In Signal Transduction and Targeted Therapy (Vol. 8, Issue 1). Springer Nature. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","DOI":"10.1038\/s41392-023-01486-5"},{"issue":"5","key":"1824_CR218","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"W Zhao","year":"2009","unstructured":"Zhao W, Townsend M (2009) Biochimica et biophysica acta insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer \u2019 s disease. BBA - Mol Basis Disease 1792(5):482\u2013496. https:\/\/doi.org\/10.1016\/j.bbadis.2008.10.014","journal-title":"BBA - Mol Basis Disease"},{"key":"1824_CR219","doi-asserted-by":"publisher","unstructured":"ZhengQ, Wang X (2024) Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16(2):83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026","DOI":"10.1093\/procel\/pwae026"},{"issue":"1","key":"1824_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-024-00712-0","volume":"19","author":"MZ Zhong","year":"2024","unstructured":"Zhong MZ, Peng T, Duarte ML, Wang M, Cai D (2024) Updates on mouse models of Alzheimer\u2019s disease. Mol Neurodegener 19(1):1\u201333. https:\/\/doi.org\/10.1186\/s13024-024-00712-0","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1824_CR221","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/mp.2014.17","volume":"20","author":"H Zhu","year":"2015","unstructured":"Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A, Hur JY, Zheng H, Li H, Fine R, Mwamburi M, Sun X, Kowall N, Stern RA, Qiu WQ (2015) Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease. Mol Psychiatry 20(2):232\u2013239. https:\/\/doi.org\/10.1038\/mp.2014.17","journal-title":"Mol Psychiatry"},{"issue":"January","key":"1824_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, Luo Z, Hu J, Peng S (2024) Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol 14(January):1\u201317. https:\/\/doi.org\/10.3389\/fendo.2023.1265372","journal-title":"Front Endocrinol"},{"key":"1824_CR223","doi-asserted-by":"publisher","unstructured":"Zilka N, Kazmerova Z, Jadhav S, Neradil P, Madari A, Obetkova D, Bugos O, Novak M (2012) Who fans the flames of Alzheimer\u2019s disease brains ? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation9(1):47. https:\/\/doi.org\/10.1186\/1742-2094-9-47","DOI":"10.1186\/1742-2094-9-47"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01824-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:24:54Z","timestamp":1774081494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01824-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":223,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01824-w","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Authors confirm that we have used ChatGPT and Grammarly to assist in improving the language and readability of our manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative Artificial intelligence (AI)"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors are grateful to the Department of Science and Technology, New Delhi, India, for providing DST-INSPIRE Fellowship to Tanya Gupta.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgement:"}}],"article-number":"64"}}